SPORTS: Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs Drug-Coated Balloons in Long SFA Lesions; HEAL Study Update

In this video, interventional angiologist Thomas Zeller, MD, from the University Heart Center Freiburg–Krozingen in Bad Krozingen, Germany, discusses 2 of his presentations from AMP 2024. The first was on the SPORTS trial, a randomized controlled trial comparing outcomes of a drug-eluting stent (Eluvia, Boston Scientific) vs a bare nitinol stent vs. a drug-coated balloon (SeQuent Please, B. Braun) in TASC C/D lesions, and the second on the HEAL registry, which collects outcomes data for the treatment of predominantly critical limb ischemia patients implanted with the MicroStent (Micro Medical Solutions) for below-the-knee intervention.